GlassScriptPhysician profile
Kenneth H Wasserman
NPI 1932112760
$7,913.26
in general payments reported to CMS, 2019-2025
52 companies · $14.78 in 2025
The $14.78 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970 · 2020: $1,249 · 2021: $1,524 · 2022: $1,364 · 2023: $1,444 · 2024: $1,347 · 2025: $14.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,798 · Education: $7.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,797.75 |
| Education | $7.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $983.06 | 2019-2024 | Rybelsus, Ozempic |
| Amgen INC. | $879.63 | 2019-2025 | Repatha, Otezla, Prolia |
| Abbvie INC. | $859.46 | 2021-2024 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $500.54 | 2019-2024 | Mounjaro |
| Pfizer INC. | $478.97 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $452.59 | 2019-2024 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $447.60 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Allergan, INC. | $253.10 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $223.50 | 2019-2024 | |
| Amarin Pharma, INC. | $215.63 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $215.54 | 2020-2023 | Ajovy, Austedo Xr |
| Bayer Healthcare Pharmaceuticals INC. | $189.54 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $180.66 | 2019-2024 | |
| Astellas Pharma US INC | $175.96 | 2019-2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.81 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $154.06 | 2019-2024 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $133.77 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $103.45 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $103.26 | 2021 | |
| Abbott Laboratories | $91.82 | 2021-2023 | Freestyle Libre |
| E.R. Squibb & Sons, L.L.C. | $83.73 | 2019-2023 | Eliquis |
| Dexcom, INC. | $71.42 | 2021-2024 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $68.00 | 2023 | Elaprase |
| Eisai INC. | $67.04 | 2020 | |
| Lundbeck LLC | $57.92 | 2019-2024 | Vyepti |
| Kowa Pharmaceuticals America, INC. | $57.68 | 2022-2024 | Zoryve |
| Biohaven Pharmaceutical Holding Company LTD. | $53.59 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $46.90 | 2022-2024 | Rexulti |
| Xeris Pharmaceuticals, INC. | $44.05 | 2023-2024 | Gvoke Hypopen |
| Exact Sciences Corporation | $41.64 | 2024 | Cologuard Collection Kit |
| Global Blood Therapeutics, INC. | $39.66 | 2020-2021 | |
| Bardy Diagnostics, INC. | $39.53 | 2020 | |
| Ge Healthcare | $39.33 | 2022 | |
| Janssen Biotech, INC. | $39.24 | 2024 | Tremfya |
| Medtronic, INC. | $30.33 | 2024 | Minimed 780g |
| Arbor Pharmaceuticals, INC. | $30.07 | 2021 | |
| Idorsia Pharmaceuticals US INC | $27.97 | 2022-2023 | Quviviq |
| Daiichi Sankyo INC. | $24.80 | 2019-2022 | |
| Aurinia Pharma U.S., INC. | $23.80 | 2024 | Lupkynis |
| Insulet Corporation | $21.11 | 2023 | Omnipod |
| Impel Pharmaceuticals INC. | $19.03 | 2023 | Trudhesa |
| Ucb, INC. | $17.73 | 2023 | Cimzia |
| Recordati_rare_diseases_inc. | $16.71 | 2024 | Signifor Lar, Isturisa |
| Currax Pharmaceuticals LLC | $16.18 | 2024 | Contrave |
| Ani Pharmaceuticals, INC. | $16.08 | 2024 | Purified Cortrophin Gel |
| Dynavax Technologies Corporation | $16.00 | 2023 | Heplisav-B |
| Ibsa Pharma INC. | $15.75 | 2024 | Tirosint, Licart |
| Sanofi Pasteur INC. | $15.58 | 2023 | |
| Esperion Therapeutics, INC. | $15.27 | 2023 | Nexletol |
| Sobi, INC | $14.26 | 2024 | |
| Jazz Pharmaceuticals INC. | $13.16 | 2021 | |
| Almatica Pharma LLC | $12.75 | 2023 | Loreev Xr, Sertraline Hcl, Gralise |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Wasserman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.